RICHARD G PESTELL
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD429307
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19123
Personal information
See more information about RICHARD G PESTELL at radaris.comName
Address
Phone
403 S 3Rd St, Philadelphia, PA 19147
403 3Rd St, Philadelphia, PA 19147
Professional information
Richard Pestell, Philadelphia PA
Work:
Thomas Jefferson University Hospital
233 S 10Th St, Philadelphia, PA 19107
233 S 10Th St, Philadelphia, PA 19107
Dr. Richard G Pestell, Philadelphia PA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Oncology
Address:
Richard G. Pestell, MD
111 S 11Th St SUITE G4240, Philadelphia 19107
(215) 503-5692 (Phone)
111 S 11Th St SUITE G4240, Philadelphia 19107
(215) 503-5692 (Phone)
Languages:
English
Hospitals:
Richard G. Pestell, MD
111 S 11Th St SUITE G4240, Philadelphia 19107
Jefferson University Hospitals - City Center
111 South 11Th St, Philadelphia 19107
111 S 11Th St SUITE G4240, Philadelphia 19107
Jefferson University Hospitals - City Center
111 South 11Th St, Philadelphia 19107
Professor And Director At Thomas Jefferson University
Location:
Greater Philadelphia Area
Industry:
Hospital & Health Care
Director At Kimmel & Associates
Location:
Greater Philadelphia Area
Industry:
Hospital & Health Care
Richard G Pestell, Philadelphia PA
Specialties:
Oncologist
Address:
615 Chestnut St, Philadelphia, PA 19106
Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
US Patent:
2012019, Jul 26, 2012
Filed:
Feb 18, 2010
Appl. No.:
13/202312
Inventors:
Michael P. Lisanti - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
International Classification:
C40B 30/04, C40B 40/10, G01N 21/64, G01N 33/566, C12Q 1/68
US Classification:
506 9, 435 71, 435 612, 435 792, 506 18
Abstract:
The invention provides diagnostic and therapeutic methods for neoplastic disease patients with neoplasms of, for example, the breast, skin, kidney, lung, pancreas, rectum and colon, prostate, bladder, epithelial, non-epithelial, lymphomas, sarcomas, melanomas, and the like, wherein the method comprises determining the level of expression o caveolin-1, caveolin-2, vimentin, calponin2, tropomyosin, gelsolin, prolyl 4-hydroxylase alpha, EF-I-delta, or M2-isoform of pyruvate kinase in stromal cells adjacent to the neoplasm.
Use Of Modulators Of Ccr5 In The Treatment Of Cancer And Cancer Metastasis
US Patent:
2013030, Nov 14, 2013
Filed:
May 14, 2013
Appl. No.:
13/893791
Inventors:
Richard G. PESTELL - Philadelphia PA, US
International Classification:
G01N 33/50, A61K 31/506, A61K 31/46
US Classification:
51421018, 435 723, 514304, 51425218, 514394, 5142305, 5142242
Abstract:
This disclosure is directed, in part, to a method of determining whether a subject having cancer is at risk for developing metastasis of the cancer. In one embodiment, the method comprises (a) obtaining a biological sample from the subject having cancer; (b) determining CCR5 expression level and/or expression level of at least one of CCR5 ligands in the biological sample; and (c) if the expression level of CCR5 and/or of at least one of CCR5 ligands determined in step (b) is increased compared to CCR5 expression level and/or expression level of at least one of CCR5 ligands in a control sample, then the subject is identified as likely at risk for developing metastasis of the cancer.
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
US Patent:
2012003, Feb 16, 2012
Filed:
Feb 19, 2010
Appl. No.:
13/202318
Inventors:
Michael P. Lisanti - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
Federica Sotgia - Philadelphia PA, US
Richard G. Pestell - Philadelphia PA, US
International Classification:
A61K 49/00, G01N 33/566, G01N 33/577, C12Q 1/02, A61K 38/17, A61K 39/395, A61K 38/18, A61K 38/21, A61K 31/565, A61K 31/5377, A61K 31/69, A61K 33/24, A61K 38/13, A61K 31/444, A61K 31/553, A61K 31/7004, A61P 35/00, C40B 30/00
US Classification:
424 91, 506 7, 435 723, 435 71, 435 29, 514 133, 4241331, 4241581, 514 77, 424 857, 514182, 5142345, 514 64, 424649, 514 199, 514332, 51421108, 514 23
Abstract:
The invention provides diagnostic and therapeutic methods for neoplastic disease patients with neoplasms of for example, the breast, skin, kidney, lung, pancreas, rectum and colon, prostate, bladder, epithelial, non-epithelial; lymphomas, sarcomas, melanomas, and the like, comprising determining the level of caveolin-1 and/or caveolin-2 in stromal cells adjacent to a neoplasm.
Methods And Compositions For The Diagnosis, Prognosis, And Treatment Of Cancer
US Patent:
2013001, Jan 10, 2013
Filed:
Jan 6, 2011
Appl. No.:
13/520759
Inventors:
Richard G. Pestell - Philadelphia PA, US
Kongming Wu - Wynnewood PA, US
Xuanmao Jiao - Rockville MD, US
Sanjay Katiyar - Vienna VA, US
Vladimir M. Popov - Philadelphia PA, US
Mathew Casimiro - Cherry Hill NJ, US
Kongming Wu - Wynnewood PA, US
Xuanmao Jiao - Rockville MD, US
Sanjay Katiyar - Vienna VA, US
Vladimir M. Popov - Philadelphia PA, US
Mathew Casimiro - Cherry Hill NJ, US
International Classification:
A61K 31/706, A61P 35/00, A61K 48/00, A61K 38/02, A61K 31/7068, A61K 39/395
US Classification:
4241581, 514 42, 514 49, 514 44 R, 514 193
Abstract:
Methods and compositions for diagnosing and treating cancer, such as breast cancer are provided. In particular, methods and compositions relating to nucleic acids encoding DACH1 and DACH1 proteins are provided.